Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev(®)), a bevacizumab biosimilar, under extended in-use conditions

INTRODUCTION: PF-06439535 (bevacizumab-bvzr; Zirabev(®)) is a bevacizumab biosimilar. The stability profile and functional activity of PF-06439535 after dilution for intravenous infusion was evaluated following extended storage conditions. METHODS: PF-06439535 drug product was diluted in 0.9% sodium...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiser, Sarah, Burns, Chris, Zartler, Edward R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302395/
https://www.ncbi.nlm.nih.gov/pubmed/35312402
http://dx.doi.org/10.1177/10781552221088020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302395/
https://www.ncbi.nlm.nih.gov/pubmed/35312402
http://dx.doi.org/10.1177/10781552221088020

Ejemplares similares